Vitreomacular Adhesion, Traction, and Macular Holes:

Slides:

Advertisements

Similar presentations

Retinal Detachment Abdulkrim Alkharashi, MD RD History: 1. Theory of distension. 2. Theory of hypotony. 3. Theory of exudation. 4. Theory of retinal.

Advertisements

 1 st reports in 1869 – Knapp (trauma) › Related to myopia, inflammation, trauma  !970’s and 80’s – most idiopathic  1990’s – reports of surgical.

Vitrectomy Outcomes in Eyes with Diabetic Macular Edema, Visual Loss, and Vitreomacular Traction Sponsored by the National Eye Institute, National Institutes.

Interpretation of SD-OCT Gella Laxmi 2009PHXF013P.

VMT e Ocriplasmin Francesco Barca Stanislao Rizzo Daniela Bacherini Azienda Ospedaliero Universitaria Careggi Firenze.

Surgical Therapy of CME Non-responsive to Medical Therapy Henry J Kaplan, MD Evans Professor of Ophthalmology Chair, Ophthalmology & Visual Sciences Director,

In the name of God. Pneumatic & Pharmacologic Vireolysis Masood Naseripour MD IUMS.

Intermediate Uveitis with VMT syndrome Rupesh Agrawal, Carlos Pavesio Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.

Introduction. Practical Perspectives in the Surgical Management of Parkinson Disease: LCIG.

The Diabetic Retinopathy Clinical Research Network

The Mechanism of Procedural Stroke Following Carotid Endarterectomy within the Asymptomatic Carotid Surgery Trial 1 Cerebrovasc Dis 2016;42:

Role of vitrectomy the treatment of diabetic macular edema

Copyright © 2014 American Medical Association. All rights reserved.

Macular Epiretinal membrane

Upfront Combination Therapy vs Step-Up Approach for PAH:

The Patient Experience With Systemic Lupus Erythematosus

Spontaneous Closure of a Full-Thickness Stage 2 Idiopathic Macular Hole without Posterior Vitreous Detachment Case Rep Ophthalmol 2013;4: DOI: /

Diabetic retinopathy에서 Macular hole

Individualizing Treatment Options in Advanced ER-Positive Breast Cancer.

In the name of God.

Introduction. TREATMENT BASED ON TUMOR SIDEDNESS IN mCRC: THE EVIDENCE AND PRACTICAL APPLICATION.

HIV-Associated Weight Loss and Wasting

COPD by the Guidelines.

Monitoring and Management of Adult Relapsed/Refractory Acute Promyelocytic Leukemia.

A Practical Guide to the Prevention of Surgical Adhesions

Updates on Emerging GLP-1 Receptor Agonists

Progression After Cancer Immunotherapy in Advanced NSCLC

Macular Hole F.Fazel:MD

IVTS Group Classification of VMA, VMT, and Macular Hole

Dual Bronchodilation in COPD: From Clinical Trial Evidence to Clinical Practice.

DRCR.net Gas for Vitreomacular Traction RCT (Protocol AG)

Optimizing Management of Advanced Bladder Cancer

Improving Management of Type 2 Diabetes in Hispanic/Latino Patients

MDS: Introduction. Supportive Care in the Treatment of Lower-Risk Myelodysplastic Syndromes.

Learning Objectives Classification of VTE Goals of VTE Treatment.

Gene Therapy: Past, Present, and Future

Over-the-Counter Allergic Rhinitis Treatments

Intermitting Photopsia caused by vitreomacular traction

Managing Polycythemia Vera in the Community Setting

When to Start and What to Use

WHAT’S NEW WITH THE TREATMENTS FOR HIGH-RISK DYSLIPIDEMIA?

Scientific Update.

Challenges in Severe Asthma

Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.

Management of Advanced Pancreatic Adenocarcinoma

Are We Making Progress in the Management of Huntington Disease?

Novel Concepts in the Management of RCC

New Paradigms in M0 CRPC.

Getting PPG Under Control

HAE Prophylaxis.

Diabetic Retinopathy Clinical Research Network

The Nurse View: Spotlight on EGFR-Mutated NSCLC

Optimizing Treatment of Refractory Gout

MS, Age, and Immune Function

Patient and Clinician Perspectives on Preventive Therapy for Migraine

Early Treatment of Diabetic Retinopathy

Tardive Dyskinesia 101.

New Options for the Treatment of Hepatocellular Carcinoma

Balancing the Risks and Benefits of Multidrug Regimens in the Clinical Management of Nontuberculous Mycobacterial Lung Disease.

Expert Insights in Diagnosis and Management of Common Drug-Induced Movement Disorders.

BRIDGING CVD AND T2DM: LESSONS LEARNED FROM OUTCOME TRIALS

Alterations with Sensory Perception

Expert Perspectives.

Foundations of Asthma.

Motor Fluctuations in PD

Management of NTM Lung Disease

Utilizing MRD Assessment in Community Practice

You Don't Know JAK in IBD.

Presentation transcript:

Vitreomacular Adhesion, Traction, and Macular Holes:

The Vitreous Body

PVD

VMA vs VMT

VMT Symptomatology: Visual Symptoms

VMT Burden

Vitreous-Related Macular Pathologies

Spontaneous VMA Resolution

Macular Holes

Visualizing and Classifying VMT

International Interface Classification

Concluding Remarks

Vitreomacular Adhesion, Traction, and Macular Holes:

Treatment Approaches for VMA, VMT, and Macular Holes

Vitreolysis Versus Vitrectomy

Vitreomacular Traction Study Group: Incidence of Post-Vitrectomy Cataract Surgery

MIVI 6/7 Trials: VMA Resolution With Ocriplasmin vs Placebo

OASIS: Data Compare Favorably to MIVI 6/7 VMA Resolution at Day 28

Predicting Ocriplasmin Success Rate With a Formula

Most Commonly Reported AEs With Ocriplasmin in the Study Eye

Ocriplasmin: Technique

Ocriplasmin: Follow-Up Procedures

Case 1: Symptomatic VMT

Case 1: Symptomatic VMT (cont)

Case 1: Symptomatic VMT (cont)

Multicolor Imaging: Avoids Overlooking Epiretinal Gliosis

Case 2: Symptomatic VMT

Case 3: VMT and Macular Hole

Case 3: VMT and Macular Hole (cont)

Case 4: VMT and Macular Hole

Case 5: VMT and Macular Hole

Case 5: VMT and Macular Hole (cont)

Concluding Remarks

Abbreviations

Abbreviations (cont)